Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Download White Paper
IT in
Healthcare,
Patient
Monitoring &
Telemedicine

Download White Paper

 
Matching geography
Reports matching your search in:
 
 
Download SlideShare
20
Hot
Stats on
Healthcare
IT

Download SlideShare

 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

1594
The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
Lithuania – Bioeconomic Outlook
5/16/2013 | published by: Oryx Business Intelligence Ltd.
... for growth in the future. The report assembles and presents the pertinent statistics along with the interpretation of statistics presented. Interspersed with 14 data tables, figures and charts, the report provides an easy to understand ...  |  read more...
$127.00
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
5/14/2013 | published by: GBI Research
... Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific”. The report provides in-depth analysis of the drivers and barriers that affect the global critical care market. The ...  |  read more...
$3,500.00
Banyan Biomarkers - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation, apoptosis, necrosis, and liver injuries. It provides biomarkers for stroke, Alzheimer’s disease, Parkinson’s and Huntington’s disease, and depression; and therapeutic candidates for neuro-protection. ...  |  read more...
$750.00
Caprion Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... discovery and clinical validation of biomarkers using its proteomics discovery platform CellCarta. Caprion’s CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious ...  |  read more...
$750.00
ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... company’s immunotherapies product pipeline comprises ICT-140, ICT-121 and ICT-107. ICT-140 is a DC vaccine designed to target seven different ovarian cancer antigens. ICT-121, is being developed for the treatment of solid tumors and ICT-107 is ...  |  read more...
$750.00
Histogenics Corporation - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... offers an alternative for treating discrete cartilage defects. The company’s products focus on the treatment of active patients suffering from articular cartilage derived pain and immobility. It manufactures products to improve the body’s ability to ...  |  read more...
$750.00
Biocortech - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... of depression; and EDITOX, drug screening assay predictive of neuropsychiatric toxicology of chemical entities. The company provides clinical diagnostic tests and drug screening assays. Biocortech has developed a vitro cell line assay to assess candidate ...  |  read more...
$750.00
Biocrates Life Sciences AG - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... nervous system disorders, gynecology, sports, nutrition, diabetics, pharmaceutical research and endocrinology. Its product portfolio includes Research Products comprising AbsoluteIDQ Kits and Diagnostic Products including MetaDisIDQKit and SteroIDQ Kit. The company offers partners with pharmaceutical, biotechnology ...  |  read more...
$750.00
CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... the company is CytoCore Solutions System, a simple and cost-effective method to screen women for endometrial cancer. It consists of four distinct components, namely, the SoftPAP cervical cell collector, the AIPS microscope platform, drug delivery ...  |  read more...
$750.00
Digna Biotech, S.L. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... key franchises, four diagnostic tests, and two research products. Digna’s therapeutic areas include P144, P17, IFN alfa 5, cardiotrophin -1 (CT-1), AAV-phorphyria, IFN +CT1 + oncostatin and MTA. The company focuses research and development in ...  |  read more...
$750.00
AbSorber AB - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... xenotransplantation, and develops techniques for removing antibodies against alpha-Gal and for reducing the immunogenicity of neural stem cells. Its products are used in the treatment of neurological disorders. The company conducts researches on developing ABO ...  |  read more...
$750.00
Adocia (ADOC) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... its BioChaperone state-of-the-art technological platform. Its pipeline products include BioChaperone PDGF for chronic wound healing, BioChaperone insulins for insulinotherapy and BioChaperone for monoclonal antibodies. The company has completed two phases I and II studies on ...  |  read more...
$750.00
Hai Kang Life Corporation Limited - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... veterinary diagnostic kits, clinical diagnostic kits, food molecular testing kits, testing and certification services for food and avian influenza virus testing services, foot-and-mouth disease (FMD) and severe acute respiratory syndrome (SARS). HK Life offers DNA-based ...  |  read more...
$750.00
XDx, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... rejection and autoimmune diseases. Gene expression patterns reflect the activity of genes in the various blood cells types. XDx provides modern genomics and bioinformatics technology to develop molecular diagnostic assays. The company pipeline product focused ...  |  read more...
$750.00
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
... selection, therapy monitoring and early detection of cancer recurrence. The market for cancer testing are comprehensively covered in Kalorama Information's Worldwide Market for Cancer Diagnostics, 5th. Edition. This report, authored by Kalorama Diagnostic Analyst Shara ...  |  read more...
$4,500.00
Celsion Corporation (CLSN) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... The company’s Lysolipid Thermally Sensitive Liposomestechnology is a unique liposomal technology, which allows for the triggered release of a drug payload through low temperature heat activation. Celsion Corporation Key Recent Developments Apr 23, 2013: Celsion ...  |  read more...
$125.00
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... consultancy services to its customers. genOway develops several technology platforms like safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe RNAi transgenesis. The company has a wide spread network with its operations being ...  |  read more...
$125.00
ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... company’s immunotherapies product pipeline comprises ICT-140, ICT-121 and ICT-107. ICT-140 is a DC vaccine designed to target seven different ovarian cancer antigens. ICT-121, is being developed for the treatment of solid tumors and ICT-107 is ...  |  read more...
$125.00
Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... malaria, respiratory syncytial virus (RSV) and Influenza. Its product pipeline consists of five vaccines, namely, HIV-1 in Phase I clinical trial; RSV in preclinical phase; Herpes Simplex Virus (HSV) in preclinical Phase; malaria vaccine has ...  |  read more...
$125.00
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... The company is developing drugs like IFN-a XL, FT-105, IL-2 XL, Tigecycline XL, hGH XL and GLP-1 XL using Medusa based technology; drugs dedicated to those children and elder patients who have difficulty in swallowing ...  |  read more...
$125.00
Ardea Biosciences, Inc. - Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... includes three pipeline products, namely, Lesinurad (RDEA 594), RDEA 3170 and Bay 86-9766 (RDEA 119). Lesinurad and RDEA 3170 are currently in Phase-III and Phase-I clinical trials respectively, being developed as a treatment for gout. ...  |  read more...
$125.00
Lescarden Inc. (LCAR) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... Catrix Wound Dressing, Catrix Skin Care and Nutritional Supplements. It offers nutritional supplements, including Bio-Cartilage, and Poly-NAG, a glucosamine polymer for the treatment of osteoarthritis. This comprehensive SWOT profile of Lescarden Inc. provides you an ...  |  read more...
$125.00
Prolor Biotech, Inc. (PBTH) - Financial and Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... a short, naturally-occurring amino acid sequence (peptide), from the Washington University in St. Louis. It uses the Carboxyl Terminal Peptide (CTP) technology for the development of certain existing therapeutic proteins that have longer life spans. ...  |  read more...
$125.00
Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review
5/3/2013 | published by: GlobalData
... and recombinant protein micelle vaccines technology. The company's product portfolio includes vaccines indicated against seasonal quadrivalent influenza, pandemic (H5N1) influenza, respiratory syncytial virus, seasonal trivalent influenza, pandemic (H1N1) influenza and rabies. Novavax established various partnerships ...  |  read more...
$125.00
Global Biochips Market 2012-2016
5/3/2013 | published by: Infiniti Research Limited
... the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. ...  |  read more...
$2,000.00
< prev 1  2  3  4  5  6  7  8  9  10  next >